Skip to content
The Atlantic
Popular
Latest
Sections
Sections
Politics
Culture
Technology
Ideas
Science
Books
Family
Business
Global
Health
Education
Letters
The Masthead
Our Towns
Photo
Podcasts
The Atlantic Crossword
Video
Events
Writers
Projects
Magazine
Magazine
Current issue
All issues
Manage subscription
Give a Gift
Subscribe
More
Categories
More
Create account
Your account
Sign in
Sign out
Newsletters
The Atlantic Crossword
iOS App
Life Timeline
Events
Books
Shop
Help Center
View all
Subscribe
Search
Search
Quick Links
Dear Therapist
Crossword Puzzle
Manage Subscription
Search The Atlantic
Quick Links
Dear Therapist
Crossword Puzzle
Manage Subscription
Derek Lowe
Why the Large Pharma Companies Are in Crisis
Derek Lowe
Feb 2, 2010
Are Big Pharma Mergers Good for New Drugs?
Derek Lowe
Jan 7, 2010
Swinging The Ax At The Drug Companies
Derek Lowe
Nov 11, 2009
R&D v. Marketing: Where Should Drug Companies Spend?
Derek Lowe
Jul 9, 2009
Heavy Atoms and Hard Times
Derek Lowe
Jun 2, 2009
Is Bay Area Biotech in Trouble?
An R&D crisis for Bay Area biotech.
Derek Lowe
May 18, 2009
GSK and Pfizer: Partnering Up?
Derek Lowe
Apr 17, 2009
Is The Blockbuster Era Over for Big Pharma?
Derek Lowe
Apr 17, 2009
Age Before Beauty, Revisited
Derek Lowe
Apr 15, 2009
Startups run dry: the numbers speak
Derek Lowe
Mar 17, 2009
Merck buys Schering-Plough: first thoughts
Derek Lowe
Mar 9, 2009
The Court reins in the FDA
Derek Lowe
Mar 5, 2009
India drug business stumbles
Derek Lowe
Mar 2, 2009
Stem cells: time to put some money down?
Derek Lowe
Feb 19, 2009
All the small startups: running dry?
Derek Lowe
Feb 13, 2009
Carl Icahn's not through with biotech yet
Derek Lowe
Feb 6, 2009
Fear and trembling in the drug companies
Derek Lowe
Feb 5, 2009
Merck and Schering-Plough make their targets
Derek Lowe
Feb 3, 2009
Outsourced science: what next?
Derek Lowe
Jan 29, 2009
The Drug Industry's Problem(s)
Derek Lowe
Jan 27, 2009
More Stories